Recurrent Small Cell Lung Cancer (SCLC) Completed Phase 2 Trials for Tyrosine (DB00135)

Also known as: Recurrent Small-cell Lung Cancer (SCLC) / Small Cell Lung Cancer Recurrent / Refractory Small cell lung cancer / Recurrent Small Cell Lung Cancer / Recurrent Lung Small Cell Carcinoma / Recurrent Small Cell Lung Carcinoma

IndicationStatusPhase
DBCOND0122754 (Recurrent Small Cell Lung Cancer (SCLC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01935336Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersTreatment